Sumitomo Mitsui Trust Holdings Inc. Has $51.88 Million Holdings in Medidata Solutions Inc (MDSO)
Sumitomo Mitsui Trust Holdings Inc. grew its position in shares of Medidata Solutions Inc (NASDAQ:MDSO) by 48.9% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 707,698 shares of the company’s stock after purchasing an additional 232,532 shares during the quarter. Sumitomo Mitsui Trust Holdings Inc. owned about 1.16% of Medidata Solutions worth $51,881,000 as of its most recent SEC filing.
A number of other institutional investors have also recently added to or reduced their stakes in the business. World Asset Management Inc acquired a new stake in shares of Medidata Solutions during the 2nd quarter worth approximately $235,000. Zeke Capital Advisors LLC acquired a new stake in shares of Medidata Solutions during the 2nd quarter worth approximately $239,000. First Republic Investment Management Inc. acquired a new stake in shares of Medidata Solutions during the 2nd quarter worth approximately $242,000. Zions Bancorporation acquired a new stake in shares of Medidata Solutions during the 2nd quarter worth approximately $274,000. Finally, Cornerstone Wealth Management LLC acquired a new stake in shares of Medidata Solutions during the 2nd quarter worth approximately $285,000.
NASDAQ MDSO opened at $68.69 on Tuesday. Medidata Solutions Inc has a 12-month low of $59.60 and a 12-month high of $88.87. The company has a debt-to-equity ratio of 0.15, a current ratio of 2.52 and a quick ratio of 2.52. The firm has a market capitalization of $4.43 billion, a P/E ratio of 80.81, a price-to-earnings-growth ratio of 4.28 and a beta of 1.30.
Several analysts have recently commented on the stock. Royal Bank of Canada set a $86.00 price objective on shares of Medidata Solutions and gave the stock a “buy” rating in a research report on Friday, October 19th. JPMorgan Chase & Co. downgraded shares of Medidata Solutions from an “overweight” rating to a “neutral” rating and set a $87.00 price objective for the company. in a research report on Tuesday, July 24th. ValuEngine downgraded shares of Medidata Solutions from a “buy” rating to a “hold” rating in a research report on Tuesday, July 24th. Morgan Stanley set a $84.00 price target on shares of Medidata Solutions and gave the company a “hold” rating in a research report on Wednesday, July 25th. Finally, Zacks Investment Research downgraded shares of Medidata Solutions from a “hold” rating to a “sell” rating in a research report on Tuesday, October 16th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and eight have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $84.64.
In other Medidata Solutions news, EVP Michael I. Otner sold 7,030 shares of Medidata Solutions stock in a transaction on Tuesday, October 23rd. The shares were sold at an average price of $69.40, for a total transaction of $487,882.00. Following the transaction, the executive vice president now directly owns 62,548 shares of the company’s stock, valued at approximately $4,340,831.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 4.70% of the stock is owned by insiders.
WARNING: This piece was posted by Daily Political and is the property of of Daily Political. If you are viewing this piece on another site, it was copied illegally and republished in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://www.dailypolitical.com/2018/11/20/sumitomo-mitsui-trust-holdings-inc-has-51-88-million-holdings-in-medidata-solutions-inc-mdso.html.
Medidata Solutions Company Profile
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.
Read More: Return on Investment (ROI)
Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions Inc (NASDAQ:MDSO).
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.